Ketorolac Tromethamine Injection, Solution
Product Images NDC 25021-701

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 25021-701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ket06 0001 01)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ket06 0002 02)

NDC 25021-700-01 is a medication called Tromethamine, available in the form of an injection. Each milliliter (mL) of the injection contains 15 mg of the active ingredient. It comes in a single-dose vial with a volume of 1 mL. The medication is manufactured by a company called SAGENT, located in Schaumburg, IL, USA. It is intended for intravenous or intramuscular use only. It should be protected from light during storage. Unfortunately, the information regarding the use or purpose of the medication is not provided in the given text. Additionally, some parts of the text are not readable due to errors.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ket06 0002 03)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ket06 0002 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.